공시 • Apr 21
Tigerless Health, Inc. entered into a definitive business combination agreement to acquire Piermont Valley Acquisition Corp (OTCPK:CMCA.F) in a reverse merger transaction for an enterprise value of approximately $280 million. Tigerless Health, Inc. entered into a definitive business combination agreement to acquire Piermont Valley Acquisition Corp (OTCPK:CMCA.F) in a reverse merger transaction for an enterprise value of approximately $280 million on April 17, 2026. The consideration consists of common equity of Piermont Valley Acquisition Corp to be issued for common equity of Tigerless Health, Inc. The consideration also includes an earnout/contingent payment. The combined company is expected to be renamed “Tigerless AI Holdings, Inc.” and trade on NASDAQ allowing Tigerless Health to continue building its proprietary artificial intelligence (AI) capabilities designed to improve how users access and navigate insurance. Accordingly, upon consummation of the Acquisition Merger and Reorganization Merger, the former stockholders of Tigerless will hold an aggregate of 5,600,000 shares of Tigerless AI Holdings, Inc Class A common stock and 22,400,000 shares of Tigerless AI Holdings, Inc Class B common stock and the former stockholders of Piermont will hold an aggregate of 5,952,886 shares of Tigerless AI Holdings, Inc Class A common stock. Existing Tigerless Health shareholders will roll 100% of their equity into the combined company upon closing of the transaction. Tigerless Health, Inc.'s management team, led by founder and CEO Zikang Wu, will continue to lead the combined company following the close of the transaction.
The transaction is subject to required regulatory approvals, approval by the stockholders of Tigerless Health, Inc. and Piermont Valley Acquisition Corp, and the satisfaction or waiver of other customary closing conditions. The deal has been unanimously approved by the board of directors of Tigerless Health, Inc. and Piermont Valley Acquisition Corp. The transaction is expected to close in the second half of 2026.
Ari Edelman of Edelman Legal Advisory PLLC acted as legal advisor to Piermont Valley Acquisition Corp. Jeffrey M. Gallant and Brian L. Ross of Graubard Miller acted as legal advisor to Tigerless Health, Inc. Continental Stock Transfer & Trust Company acted as information agent to Piermont Valley Acquisition Corp. 공시 • Sep 06
The Nasdaq Stock Market to Delist Ordinary Shares of Capitalworks Emerging Markets Acquisition The Nasdaq Stock Market announced that it will delist the ordinary shares, units, and warrants of Capitalworks Emerging Markets Acquisition Corp. The company’s Securities were suspended on June 12, 2024, and have not traded on Nasdaq since that time. 공시 • Aug 15
Capitalworks Emerging Markets Acquisition Corp announced delayed 10-Q filing On 08/14/2024, Capitalworks Emerging Markets Acquisition Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC. 공시 • Jul 03
Capitalworks Emerging Markets Acquisition Corp announced delayed annual 10-K filing On 07/02/2024, Capitalworks Emerging Markets Acquisition Corp announced that they will be unable to file their next 10-K by the deadline required by the SEC. 공시 • Jun 13
Capitalworks Emerging Markets Acquisition Corp(NasdaqGM:CMCA) dropped from NASDAQ Composite Index Capitalworks Emerging Markets Acquisition Corp has been dropped from NASDAQ Composite Index . 공시 • Apr 26
Capitalworks Emerging Markets Acquisition Receives Notice from Nasdaq Indicates it Did Not Regain Compliance with the Minimum Total Holders Rule During the Extension Period As previously reported, on September 7, 2023, Capitalworks Emerging Markets Acquisition Corp. (the ‘Company’) received a written notice from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market (the ‘Nasdaq’) indicating that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(2), which requires the Company to maintain at least 400 total holders for continued listing on the Nasdaq Global Market (the ‘Minimum Total Holders Rule’). Pursuant to Nasdaq Listing Rule 5810(c)(2)(B)(i), the maximum amount of time for the Company to regain compliance with the Minimum Total Holders Rule is 180 days, or until March 5, 2024 (the ‘Extension Period’). On March 15, 2024, the Company submitted an application to transfer its securities to the Nasdaq Capital Market and paid $5,000 application fee. Nasdaq indicated that the Company does not currently meet the 300 public holder requirement for continued listing on the Nasdaq Capital Market. On April 18, 2024, the Company received a notice (the ‘Notice’) from Nasdaq indicating that the Company did not regain compliance with the Minimum Total Holders Rule during the Extension Period. Pursuant to the Notice, unless the Company requests a hearing before the Nasdaq Hearings Panel (the ‘Panel’) by April 25, 2024, the Company’s securities would be subject to suspension and delisting from the Nasdaq Global Market at the opening of business on April 29, 2024, and a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove the Company’s securities from listing and registration on Nasdaq. The Company intends to timely request a hearing before the Panel to appeal the Notice. The hearing request will stay the suspension of trading on the Company’s securities, and the Company’s securities will continue to trade on the Nasdaq Global Market until the hearing process concludes and the Panel issues a written decision. There can be no assurance that the hearing before the Panel will be successful. 